Hirokazu Takahashi

24PUBLICATIONS
232CO-AUTHORS
Metabolic medicineCardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 17, 2026
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

|Jun 14, 2026
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

|Mar 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests.

Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai

|Jan 14, 2026
Imaging-Based Modalities for Identifying At Risk MASH. A Diagnostic Test Meta-Analysis.

Shyna Zhuoying Gunalan, Michelle Shi Ni Law, Yi Xin Kua

|Dec 24, 2025
BCAA (Branched-Chain Amino Acids) Inhibiting the Autophagy System via the Activation of mTORC1, Thereby Upregulating the Tumor Suppressor PDCD4 in Huh7 Hepatoma Cells.

Rasheda Perveen, Iwata Ozaki, Hirokazu Takahashi

|Dec 12, 2025
Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.

Jie Li, Joanne Kimiko Liu, Angela Chau

Pageof 4

Frequent Collaborators

6 joint publications

Yoshio Sumida

6 joint publications

Atsushi Nakajima

6 joint publications

Hidenori Toyoda

5 joint publications

Takumi Kawaguchi